Evaluation of Some Immunological Aspects of Women with Polycystic Ovary Syndrome in Wasit Governorate
Abstract
The aim of the study the Study immune linkage for the occurrence of cysts and Analyzing the results statistically to determine the extent of the immunological causes of the occurrence of polycysticovaries.Polycystic ovary syndrome (PCOS) is one of the commonest endocrine disorders affecting many females in reproductive period which start from menarche till the menopause and commonly caused infertility around the world, and is characterized by irregular menstrual cycle, Hyperandrogensim and polycystic ovary; it can be considered a conditions involving reproductive, metabolic and cardiovascular components leading to lifelong health implication. Its prevalence among infertile women is between (15% to 20%). There is evidence that PCOS is a pro inflammatory disorder, characterized by the presence of low grade chronic inflammation that correlated with obesity or insulin resistance (IR). The present study aims to determine the role of immunological and physiological response in the pathogenesis of PCOS. The current study included 100 females diagnosed with PCOS, there were recruited from Kamal Al-kut hospital in Wasit during November 2022 until January 2023 , the diagnosis of polycystic ovary syndrome was based on the Rotterdam 2003 criteria. The control group consists of 50 fertile women who have regular menstrual cycle with no sign of hyperandrogenism and subjected to ultrasound examination and have normal hormonal levels. The age was identical in both groups and it was between (20-40) years.
The present study was carried out in two parts: immunological study. ELISA technique has been used to determine the serum level of Interlukine-15and IL6.
The results of immunological study demonstrated that IL-15 andIL6 serum level were significantly increased (p<0.005)in pcos patients in comparison to control group. The mean level of that interleukin in patients and control group were (33.991±.57) pg/mL and (36.041±.03) and IL6 (85.944±.29), (84.24±6.39) pg/mL respectively.
Conclusions: In patients with pcos, The plasma level of IL-15, IL-6 is a major independent inflammatory predictor. Also, a ncrease in this hormone levels is an important indicator in predicting polycystic ovary syndrome.
References
2. Bernabeu, I., Alvarez-Escola, C., Quinteiro, C., Lucas, T., Puig-Domingo, M., Luque-Ramírez, M., ... & Marazuela, M. (2010). The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly. The Journal of Clinical Endocrinology & Metabolism, 95(1), 222-229.
3. Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021). mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nature reviews Drug discovery, 20(11), 817-838.
4. Chouhan, L., Ito, S., Thomas, E. M., Takano, Y., Ghimire, S., Miyasaka, H., & Biju, V. (2021). Real-time blinking suppression of perovskite quantum dots by halide vacancy filling. ACS nano, 15(2), 2831-2838.
5. Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., ... & Yildiz, B. O. (2014). The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. European journal of endocrinology, 171(4), P1-P29.
6. Deswal, R., Narwal, V., Dang, A., & Pundir, C. S. (2020). The prevalence of polycystic ovary syndrome: a brief systematic review. Journal of human reproductive sciences, 13(4), 261.
7. Ghatnatti, V., Patil, S., & Kour, H. (2022). Assessment of clinical, biochemical, and hormonal profile of lean versus overweight polycystic ovarian syndrome patients: a cross-sectional study. APIK Journal of Internal Medicine, 10(1), 13-16.
8. Giri, J. G., Kumaki, S., Ahdieh, M., Friend, D. J., Loomis, A., Shanebeck, K., ... & Anderson, D. M. (1995). Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. The EMBO journal, 14(15), 3654-3663.
9. Grapsa, D., Kairi-Vassilatou, E., Kleanthis, C., Dastamani, C., Fillipidou, A., & Kondi-Pafiti, A. (2011). Epithelial ovarian tumors in adolescents: a retrospective pathologic study and a critical review of the literature. Journal of Pediatric and Adolescent Gynecology, 24(6), 386-388.
10. Habib, A., & Hasan, M. M. (2017). Social capital and corporate cash holdings. International Review
11. Laporte, J. R., Ibanez, L., Vidal, X., Vendrell, L., & Leone, R. (2004). Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug safety, 27, 411-420.
12. Murri, M., Luque-Ramírez, M., Insenser, M., Ojeda-Ojeda, M., & Escobar- Morreale, H. F. (2013). Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Human reproduction update, 19(3), 268-288.
13. Villa, J., & Pratley, R. E. (2011). Adipose tissue dysfunction in polycystic ovary syndrome. Current diabetes reports, 11, 179-184.
14. Wang, Y., Bryant, S. H., Cheng, T., Wang, J., Gindulyte, A., Shoemaker, B. A.,... & Zhang, J. (2017). Pubchem bioassay: 2017 update. Nucleic acids research, 45(D1), D955-D963.
15. Zoued, A., Brunet, Y. R., Durand, E., Aschtgen, M. S., Logger, L., Douzi, B., ... & Cascales, E. (2014). Architecture and assembly of the Type VI secretion system. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1843(8), 1664-1673.
16. Borruel, S., Moltó, J. F., Alpanes, M., Fernandez-Duran, E., Alvarez-Blasco, F., Luque-Ramirez, M., & Escobar-Morreale, H. F. (2014). Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index. PloS one, 9(12), e114112.
17. Cao, L., Huang, C., Zhou, D. C., Hu, Y., Lih, T. M., Savage, S. R., ... & Zhao, G. (2021). Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell, 184(19), 5031-5052.
18. Dunaif, A., Chang, R. J., Franks, S., & Legro, R. S. (Eds.). (2008). Polycystic ovary syndrome: current controversies, from the ovary to the pancreas. Springer Science & Business Media.
19. Escobar-Morreale, H. F. (2012). Iron metabolism and the polycystic ovary syndrome. Trends in Endocrinology & Metabolism, 23(10), 509-515.
20. Escobar‐Morreale, H. F., Calvo, R. M., Villuendas, G., Sancho, J., & San Millán, J. L. (2003). Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obesity research, 11(8), 987-996.
21. Falconer, J. D. (2009). Mitigation studies of the airfoil-vortex interaction using Large Eddy Simulation (Doctoral dissertation, Carleton University).
22. Huang, S., Papernot, N., Goodfellow, I., Duan, Y., & Abbeel, P. (2017). Adversarial attacks on neural network policies. arXiv preprint arXiv:1702.02284.
23. Jakubowska, D., & Radzymińska, M. (2009). Postawy i zachowania nabywcze konsumentów wybranych narodowości wobec ryzyka związanego z konsumpcją produktów mięsnych. Zeszyty Naukowe Ostrołęckiego Towarzystwa Naukowego, 23, 245-252.
24. Jia, R., Duan, Y., Fang, Q., Wang, X., & Huang, J. (2016). Pyridine-grafted chitosan derivative as an antifungal agent. Food chemistry, 196, 381-387.
25. Liao, K. H., Lin, Y. S., Macosko, C. W., & Haynes, C. L. (2011). Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS applied materials & interfaces, 3(7), 2607-2615.
26. Lin, Y. S., Chen, H. J., Huang, J. P., Lee, P. C., Tsai, C. R., Hsu, T. F., & Huang, W. Y. (2017). Kinetics of tyrosinase inhibitory activity using Vitis vinifera leaf extracts. BioMed Research International, 2017.
27. Möhlig, M., Spranger, J., Osterhoff, M., Ristow, M., Pfeiffer, A. F., Schill, T., ... & Schöfl, C. (2004). The polycystic ovary syndrome per se is not associated with increased chronic inflammation. European Journal of Endocrinology, 150(4), 525- 532.
28. Murri, M., Luque-Ramírez, M., Insenser, M., Ojeda-Ojeda, M., & Escobar- Morreale, H. F. (2013). Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Human reproduction update, 19(3), 268-288.
29. Peyrin-Biroulet, L., Gonzalez, F., Dubuquoy, L., Rousseaux, C., Dubuquoy, C., Decourcelle, C., ... & Desreumaux, P. (2012). Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut, 61(1), 78-85.
30. Qin, J., Liu, Y., & Grosvenor, R. (2016). A categorical framework of manufacturing for industry 4.0 and beyond. Procedia cirp, 52, 173-178. of Economics & Finance, 52, 1-20.
31. Ramprasad, R., Chaudhary, V., Adya, A., & Deshwal, V. (2020). Quadratus Lumborum Bock for Postoperative Analgesia Following Total Hip Arthroplasty. Journal of Advanced Medical and Dental Sciences Research, 8(8), 91- 95.
32. Seitenzahl, I. R., Ciaraldi-Schoolmann, F., Röpke, F. K., Fink, M., Hillebrandt, W., Kromer, M., ... & Taubenberger, S. (2013). Three-dimensional delayed-detonation models with nucleosynthesis for Type Ia supernovae. Monthly Notices of the Royal Astronomical Society, 429(2), 1156-1172.
33. Sirmans, S. M., & Pate, K. A. (2013). Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical epidemiology, 1-13.
34. Sirmans, S. M., & Pate, K. A. (2013). Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical epidemiology, 1-13.
35. Tomović, G. M., Mihailović, N. L., Tumi, A. F., Gajić, B. A., Mišljenović, T. D., & Niketić, M. S. (2013). Trace metals in soils and several Brassicaceae plant species from serpentine sites of Serbia. Archives of Environmental Protection, 39(4).
36. Vernon, G., Baranova, A., & Younossi, Z. M. (2011). Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐ alcoholic steatohepatitis in adults. Alimentary pharmacology & therapeutics, 34(3), 274-285.